In addition, CHE treatment decreased the protein level of B‐cell lymphoma‐2 (Bcl‐2) and increased the Bcl‐2 associated X protein (Bax) level in two renal cancer cell lines (Figure 2E,H). The gene discussed is BCL2; the disease is renal carcinoma.